Literature DB >> 35190363

Multiple intracardiac benign tumors treated with low-dose everolimus.

Meryem Beyazal1, Ahmet Özyazıcı2, Şule Yeşil3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35190363      PMCID： PMC8878913          DOI： 10.5152/AnatolJCardiol.2021.60

Source DB:  PubMed          Journal:  Anatol J Cardiol        ISSN： 2149-2263            Impact factor:   1.596


× No keyword cloud information.
  7 in total

1.  Everolimus: a challenging drug in the treatment of multifocal inoperable cardiac rhabdomyoma.

Authors:  Haci Ahmet Demir; Filiz Ekici; Arzu Yazal Erdem; Suna Emir; Bahattin Tunç
Journal:  Pediatrics       Date:  2012-06-25       Impact factor: 7.124

2.  Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex.

Authors:  Isabelle Goyer; Nagib Dahdah; Philippe Major
Journal:  Pediatr Neurol       Date:  2015-01-14       Impact factor: 3.372

Review 3.  Giant left ventricular rhabdomyoma treated successfully with everolimus: case report and review of literature.

Authors:  Alfonso Martínez-García; Carolina Michel-Macías; Guadalupe Cordero-González; Karla I Escamilla-Sánchez; Mónica Aguinaga-Ríos; Alejandra Coronado-Zarco; Jorge A Cardona-Pérez
Journal:  Cardiol Young       Date:  2018-05-15       Impact factor: 1.093

Review 4.  Cardiac Tumors in Pediatric Patients: A Systematic Review.

Authors:  Aspasia Tzani; Ilias P Doulamis; Konstantinos S Mylonas; Dimitrios V Avgerinos; Dimitrios Nasioudis
Journal:  World J Pediatr Congenit Heart Surg       Date:  2017-09

5.  Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial.

Authors:  David Neal Franz; Elena Belousova; Steven Sparagana; E Martina Bebin; Michael Frost; Rachel Kuperman; Olaf Witt; Michael H Kohrman; J Robert Flamini; Joyce Y Wu; Paolo Curatolo; Petrus J de Vries; Vicky H Whittemore; Elizabeth A Thiele; James P Ford; Gaurav Shah; Helene Cauwel; David Lebwohl; Tarek Sahmoud; Sergiusz Jozwiak
Journal:  Lancet       Date:  2012-11-14       Impact factor: 79.321

6.  Treatment strategies for pediatric patients with primary cardiac and pericardial tumors: a 30-year review.

Authors:  Thomas Günther; Christian Schreiber; Christian Noebauer; Andreas Eicken; Ruediger Lange
Journal:  Pediatr Cardiol       Date:  2008-07-04       Impact factor: 1.655

7.  Regression of Neonatal Cardiac Rhabdomyoma in Two Months Through Low-Dose Everolimus Therapy: A Report of Three Cases.

Authors:  Jeng-Sheng Chang; Ping-Yun Chiou; Shu-Hui Yao; I-Ching Chou; Ching-Yuang Lin
Journal:  Pediatr Cardiol       Date:  2017-08-05       Impact factor: 1.655
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.